(CANF)Mkt-Cap $9 M--O/S 4 M -Phase 2 readout of NASH trial IIMMINENT--Additional 3 Drugs in Phase 3 =2000%++ GEM ..LIFETIME OPP https://content.equisolve.net/canfite/media/da26e454bef851b0c93729dbceda9a01.pdf